Regulatory News
Tuesday, August 30, 2016
BRIEF-FDA accepts Mitsubishi Tanabe Pharma's NDA filing for Edaravone to treat ALS
* FDA accepts Mitsubishi Tanabe Pharma's NDA filing for
Edaravone to treat ALS
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment